GW&K Investment Management, LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1082917
BOSTON, MA
Position in ARQT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$23,286,397
-$6,002,765 QoQ
Shares Held
988,387
-2.0% QoQ
Ownership
0.790%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 93.2869412487214.ToString("F0")%
Shared 6.670160574754626.ToString("F0")%
None 0.0428981765239729.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $699,704,251 across 25 Biotechnology names. ARQT ranks #12 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
623,048 | $101,880,808 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,393,875 | $90,086,140 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
962,643 | $71,485,868 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
371,098 | $70,156,076 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,618,686 | $58,790,674 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
779,349 | $58,521,315 | |
| 7 | VCEL |
Vericel Corp
|
1,616,855 | $52,014,225 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,214,901 | $41,100,100 |
All Filings in ARQT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,286,397 | 988,387 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $29,289,162 | 1,008,580 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $22,092,972 | 1,172,041 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,325,616 | 1,378,432 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $23,650,979 | 1,512,211 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $21,509,089 | 1,544,084 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $14,820,759 | 1,593,630 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $15,512,204 | 1,667,979 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $17,057,617 | 1,721,253 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,298,249 | 1,640,325 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $10,987,944 | 2,069,293 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $19,657,368 | 2,062,683 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $20,951,942 | 1,904,722 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $22,969,806 | 1,552,014 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $17,369,326 | 908,913 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $14,420,007 | 676,678 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,092,750 | 212,500 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||